20 Best Yielding Large-Cap Healthcare Stocks With Low Volatility
Dividend Yield | Apr 02, 2013 06:55AM ET
This article discusses the highest yielding, large cap stocks from the healthcare sector that are less volatile than the market.
It’s very important when you invest money that you have a clear idea of your risk exposure. It doesn’t make sense in my view to enter big risk positions without a higher return. Every loss you can avoid is also a return you don’t need to work out.
Below is a sheet of the 20 best yielding healthcare dividend stocks with a market capitalization of more than USD 10 billion as well as a beta ratio under one. Two of the results are High-Yields and fourteen are recommended to buy. The majored drug manufactures is still the dominating group in the screen, followed by a gaining medical instruments and supplies industry.
Baxter International (BAX) has a market capitalization of $39.47 billion. The company employs 51,000 people, generates revenue of $14.190 billion and has a net income of $2.326 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3.741 billion. The EBITDA margin is 26.36 percent (the operating margin is 20.36 percent and the net profit margin 16.39 percent).
Financial Analysis: The total debt represents 29.08 percent of the company’s assets and the total debt in relation to the equity amounts to 85.47 percent. Due to the financial situation, a return on equity of 34.40 percent was realized. Twelve trailing months earnings per share reached a value of $4.18. Last fiscal year, the company paid $1.57 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.29, the P/S ratio is 2.77 and the P/B ratio is finally 5.69. The dividend yield amounts to 2.49 percent and the beta ratio has a value of 0.51.
Stryker Corporation (SYK) has a market capitalization of $24.84 billion. The company employs 21,241 people, generates revenue of $8.657 billion and has a net income of $1.298 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.227 billion. The EBITDA margin is 25.72 percent (the operating margin is 20.11 percent and the net profit margin 14.99 percent).
Financial Analysis: The total debt represents 12.97 percent of the company’s assets and the total debt in relation to the equity amounts to 20.31 percent. Due to the financial situation, a return on equity of 15.95 percent was realized. Twelve trailing months earnings per share reached a value of $3.39. Last fiscal year, the company paid $0.85 in the form of dividends to shareholders.
Get The News You Want
Market Valuation: Here are the price ratios of the company: The P/E ratio is 19.28, the P/S ratio is 2.85 and the P/B ratio is finally 2.89. The dividend yield amounts to 1.62 percent and the beta ratio has a value of 0.92.
Covidien (COV) has a market capitalization of $31.95 billion. The company employs 43,400 people, generates revenue of $11.852 billion and has a net income of $1.902 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3.044 billion. The EBITDA margin is 25.68 percent (the operating margin is 20.34 percent and the net profit margin 16.05 percent).
Financial Analysis: The total debt represents 22.64 percent of the company’s assets and the total debt in relation to the equity amounts to 47.70 percent. Due to the financial situation, a return on equity of 18.66 percent was realized. Twelve trailing months earnings per share reached a value of $3.93. Last fiscal year, the company paid $0.94 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.20, the P/S ratio is 2.70 and the P/B ratio is finally 3.03. The dividend yield amounts to 1.54 percent and the beta ratio has a value of 0.88.
Take a closer look at the full list of the best yielding healthcare stocks that are less volatile than the market. The average P/E ratio amounts to 17.72 and forward P/E ratio is 12.83. The dividend yield has a value of 3.05 percent. Price to book ratio is 3.52 and price to sales ratio 2.70. The operating margin amounts to 20.23 percent and the beta ratio is 0.66. Stocks from the list have an average debt to equity ratio of 0.68.
Here is the full table with some fundamentals (TTM):
Related stock ticker symbols:
AZN, GSK, MRK, NVS, LLY, BMY, PFE, SNY, JNJ, SNN, TEVA, STJ, BAX,
WLP, MDT, BDX, AMGN, SYK, ABT, COV
Disclosure: I am long GSK, AZN, JNJ, SNN, BAX, MDT, BDX and SYK. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.